a disease that might affect hepatic or renal function, contraindications to opioid analgesics, fetal growth retardation, signs of fetal asphyxia by cardiotocography, meconium stained amniotic fluid or placental insufficiency. The subjects should not have received fentanyl during the previous 14 days.

NCT02571179_exc_T1
Condition
disease
NCT02571179_exc_T2
Qualifier
affect hepatic function
NCT02571179_exc_T3
Qualifier
affect renal function
NCT02571179_exc_T4
Condition
contraindications
NCT02571179_exc_T5
Drug
opioid analgesics
NCT02571179_exc_T6
Condition
fetal growth retardation
NCT02571179_exc_T7
Condition
fetal asphyxia
NCT02571179_exc_T8
Mood
signs of
NCT02571179_exc_T9
Procedure
cardiotocography
NCT02571179_exc_T10
Condition
meconium stained amniotic fluid
NCT02571179_exc_T11
Condition
placental insufficiency
NCT02571179_exc_T12
Scope
affect hepatic or renal function
NCT02571179_exc_T13
Drug
fentanyl
NCT02571179_exc_T14
Negation
not
NCT02571179_exc_T15
Temporal
during the previous 14 days